(HAPO) study. 3, 4 Fifteen institutional review boards approved our protocol, and none rejected the trial on ethical grounds. In addition, an independent data and safety monitoring committee regularly reviewed the trial. Some participants would not even have met the criteria for gestational diabetes (more evidence of clinical equipoise). We strongly disagree with an assertion that we unnecessarily exposed participants to harm. Randomized trials are necessary provided that there is sufficient uncertainty and that the results will resolve the dispute among physicians, which was the case for the treatment of mild gestational diabetes. 5 We agree that our results may encourage previously reluctant physicians to treat gestational diabetes, but such treatment is now supported by evidence from a clinical trial rather than by expert opinion alone. Mark B. Landon, M.D.
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comes trial: answers but still more questions about the management of gestational diabetes. Diabet Med 2008;25:1013-4.
Dectin-1 Deficiency and Mucocutaneous Fungal Infections
To the Editor: Mucocutaneous candidiasis is commonly seen in persons with deficient T-cellmediated immunity, including newborn infants, patients with the acquired immunodeficiency syndrome, and those with genetically defined primary T-cell deficiencies. CARD9, the caspase recruitment domain-containing protein 9. 3 The fact that dectin-1 deficiency increases susceptibility to mucocutaneous, but not systemic, fungal infections stresses the specific role that dectin-1 may have in mucosal antifungal host defense. This is not in conflict with a role of NEMO (the inhibitor of kappa light polypeptide gene enhancer in B cells, kinase gamma), IRAK-4 (the interleukin-1 receptor-associated kinase 4), or MyD88 (the protein encoded by myeloid differentiation primary response gene 88) for the host defense against systemic bacterial or fungal infections, since these are adaptor molecules specific for toll-like receptors, a different class of pattern-recognition receptors. 4 The suggestion by Saijo et al. 5 in their study that dectin-1 is not involved in the host defense against systemic candidiasis in mice reinforces the conclusion that dectin-1 may be specific for mucosal antifungal defense.
To the Editor: Although their intent is unquestionably noble, Brownell and coauthors do not produce an economic rationale for a soda tax; they merely present one side of the economic equation (cost-harm) without consideration of its usefulness. To maintain liberty, we defer to individual persons to balance the cost-utility equation. However, the authors point to market failure as a justification for intervention. Their first two rationales involve the argument that the population lacks the capacity to make free economic decisions. In attempting to restrict peoples' liberty, the onus is on the authors to convincingly
